Tsuyoshi Ohnishi1,2,3, Miho Kimachi1, Shingo Fukuma4, Tadao Akizawa5, Shunichi Fukuhara1,2. 1. Department of Healthcare Epidemiology, School of Public Health and. 2. Center for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima City, Fukushima, Japan. 3. Institute for Health Outcomes and Process Evaluation Research (iHope International), Nakagyoku, Kyoto, Japan; and. 4. Human Health Sciences, Kyoto University Graduate School of Medicine, Sakyoku, Kyoto, Japan; fukuma.shingo.3m@kyoto-u.ac.jp. 5. Division of Nephrology, Showa University School of Medicine, Tokyo, Japan.
Abstract
BACKGROUND AND OBJECTIVES: Almost half of patients on dialysis demonstrate a postdialysis serum potassium ≤3.5 mEq/L. We aimed to examine the relationship between postdialysis potassium levels and all-cause mortality. DESIGN, SETTING, PATIENTS, & MEASUREMENTS: We conducted a cohort study of 3967 participants on maintenance hemodialysis from the Dialysis Outcomes and Practice Patterns Study in Japan (2009-2012 and 2012-2015). Postdialysis serum potassium was measured repeatedly at 4-month intervals and used as a time-varying variable. We estimated the hazard ratio of all-cause mortality rate using Cox hazard regression models, with and without adjusting for time-varying predialysis serum potassium. Models were adjusted for baseline characteristics and time-varying laboratory parameters. We also analyzed associations of combinations of pre- and postdialysis potassium with mortality. RESULTS: The age of participants at baseline was 65±12 years (mean±SD), 2552 (64%) were men, and 96% were treated with a dialysate potassium level of 2.0 to <2.5 mEq/L. The median follow-up period was 2.6 (interquartile range, 1.3-2.8) years. During the follow-up period, 562 (14%) of 3967 participants died, and the overall mortality rate was 6.7 per 100 person-years. Compared with postdialysis potassium of 3.0 to <3.5 mEq/L, the hazard ratios of postdialysis hypokalemia (<3.0 mEq/L) were 1.84 (95% confidence interval, 1.44 to 2.34) in the unadjusted model, 1.44 (95% confidence interval, 1.14 to 1.82) in the model without adjusting for predialysis serum potassium, and 1.10 (95% confidence interval, 0.84 to 1.44) in the model adjusted for predialysis serum potassium. The combination of pre- and postdialysis hypokalemia was associated with the highest mortality risk (hazard ratio, 1.72; 95% confidence interval, 1.35 to 2.19, reference; pre- and postdialysis nonhypokalemia). CONCLUSIONS: Postdialysis hypokalemia was associated with mortality, but this association was not independent of predialysis potassium.
BACKGROUND AND OBJECTIVES: Almost half of patients on dialysis demonstrate a postdialysis serum potassium ≤3.5 mEq/L. We aimed to examine the relationship between postdialysis potassium levels and all-cause mortality. DESIGN, SETTING, PATIENTS, & MEASUREMENTS: We conducted a cohort study of 3967 participants on maintenance hemodialysis from the Dialysis Outcomes and Practice Patterns Study in Japan (2009-2012 and 2012-2015). Postdialysis serum potassium was measured repeatedly at 4-month intervals and used as a time-varying variable. We estimated the hazard ratio of all-cause mortality rate using Cox hazard regression models, with and without adjusting for time-varying predialysis serum potassium. Models were adjusted for baseline characteristics and time-varying laboratory parameters. We also analyzed associations of combinations of pre- and postdialysis potassium with mortality. RESULTS: The age of participants at baseline was 65±12 years (mean±SD), 2552 (64%) were men, and 96% were treated with a dialysate potassium level of 2.0 to <2.5 mEq/L. The median follow-up period was 2.6 (interquartile range, 1.3-2.8) years. During the follow-up period, 562 (14%) of 3967 participants died, and the overall mortality rate was 6.7 per 100 person-years. Compared with postdialysis potassium of 3.0 to <3.5 mEq/L, the hazard ratios of postdialysis hypokalemia (<3.0 mEq/L) were 1.84 (95% confidence interval, 1.44 to 2.34) in the unadjusted model, 1.44 (95% confidence interval, 1.14 to 1.82) in the model without adjusting for predialysis serum potassium, and 1.10 (95% confidence interval, 0.84 to 1.44) in the model adjusted for predialysis serum potassium. The combination of pre- and postdialysis hypokalemia was associated with the highest mortality risk (hazard ratio, 1.72; 95% confidence interval, 1.35 to 2.19, reference; pre- and postdialysis nonhypokalemia). CONCLUSIONS: Postdialysis hypokalemia was associated with mortality, but this association was not independent of predialysis potassium.
Authors: Michel Jadoul; Jyothi Thumma; Douglas S Fuller; Francesca Tentori; Yun Li; Hal Morgenstern; David Mendelssohn; Tadashi Tomo; Jean Ethier; Friedrich Port; Bruce M Robinson Journal: Clin J Am Soc Nephrol Date: 2012-03-08 Impact factor: 8.237
Authors: Patrick H Pun; Ruediger W Lehrich; Emily F Honeycutt; Charles A Herzog; John P Middleton Journal: Kidney Int Date: 2010-09-01 Impact factor: 10.612
Authors: Ronald L Pisoni; Brenda W Gillespie; David M Dickinson; Kenneth Chen; Michael H Kutner; Robert A Wolfe Journal: Am J Kidney Dis Date: 2004-11 Impact factor: 8.860
Authors: Simon Correa; Katherine Mikovna Scovner; James A Tumlin; Prabir Roy-Chaudhury; Bruce A Koplan; Alexandru I Costea; Vijay Kher; Don Williamson; Saurabh Pokhariyal; Candace K McClure; Finnian R Mc Causland; David M Charytan Journal: Kidney360 Date: 2021-04-29
Authors: Cosmin Cojocaru; Adelina Pupăză; Corneliu Iorgulescu; Sebastian Onciul; Lucian Câlmâc; Radu Vătăşescu Journal: Front Cardiovasc Med Date: 2022-05-30
Authors: John K Leypoldt; Michael A Kraus; Bertrand L Jaber; Eric D Weinhandl; Allan J Collins Journal: BMC Nephrol Date: 2019-07-09 Impact factor: 2.388
Authors: Pierre Delanaye; François Krzesinski; Bernard E Dubois; Alexandre Delcour; Sébastien Robinet; Caroline Piette; Jean-Marie Krzesinski; Patrizio Lancellotti Journal: Clin Kidney J Date: 2019-11-26
Authors: Esther N M de Rooij; Friedo W Dekker; Saskia Le Cessie; Ewout J Hoorn; Johan W de Fijter; Ellen K Hoogeveen Journal: Kidney Med Date: 2021-10-22
Authors: Steven Fishbane; Martin Ford; Masafumi Fukagawa; Kieran McCafferty; Anjay Rastogi; Bruce Spinowitz; Konstantin Staroselskiy; Konstantin Vishnevskiy; Vera Lisovskaja; Ayman Al-Shurbaji; Nicolas Guzman; Sunil Bhandari Journal: Kidney Int Rep Date: 2022-01-28